Articles In Press
Back to the articles list |
Back to browse issues page
1- Department of Cancer Research, Iraqi Center for Cancer and Medical Genetic Research, Mustansiriyah University, Baghdad, Iraq , raghad.shihab@uomustansiriyah.edu.iq
2- Department of Microbiology, College of medicine, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq
3- Department of Applied Pathological Analysis College of Science Al-Nahrain University, Baghdad, Iraq
2- Department of Microbiology, College of medicine, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq
3- Department of Applied Pathological Analysis College of Science Al-Nahrain University, Baghdad, Iraq
Abstract: (70 Views)
Background and Aim: A collection of hereditary hemoglobin disorders known as thalassemia are typified by uneven globin-chain output due to inadequate production of at least one globin chain. Toxoplasma (T.) gondii parasitizes reside in human body as intermediate and final hosts without any symptom. Only congenitally-infected children and immunocompromised people typically exhibit severe illness of toxoplasmosis. This study aimed to determine the CD4 and CD8 count in patients with β-thalassemia major (BTM) infected with toxoplasmosis.
Material and Methods: Ninety blood samples from BTM, BTM with toxoplasmosis, and negative control groups were selected. Among the samples, 70 were from patients with BTM, while the remaining 20 samples came from healthy people as control subjects. The IgG and IgM antibody levels against T. gondii were quantified using chemiluminescent microparticle immunoassay (CMIA) and CD4 and CD8 T cell count was measured using ELISA kits.
Results: The CMIA results from antibody levels demonstrated significant differences (P<0.001) between BTM patients with toxoplasmosis and negative control group. The CD4 & CD8 T cell counting of BTM patients with toxoplasmosis showed highly significant difference (P<0.0001) compared to their controls.
Conclusion: Counting CD4 and CD8 T lymphocytes in individuals with BTM who have contracted toxoplasmosis offered important information about their immune response and how to treat the illness. Tracking these subsets can help direct clinical interventions and enhance the patients’ outcomes, especially when chronic infection and immunological fatigue are involved.
Type of Study: Original Research Article |
Subject:
Medical Parasitology
Received: 2025/05/23 | Accepted: 2025/08/3 | ePublished: 2025/08/18
Received: 2025/05/23 | Accepted: 2025/08/3 | ePublished: 2025/08/18
References
1. Alwan ES, Juda TM, Majed LM. Assessment of B2-Microglobulin Analysis for Renal Insufficiency in Iraqi β-Thalassemia Major Patients. Al-Mustansiriyah J Sci. 2024;35(3):15-21. [DOI:10.23851/mjs.v35i3.1391]
2. Kattamis A, Kwiatkowski JL, Aydinok Y. Thalassaemia. Lancet. 2022;399(10343):2310-24. [DOI:10.1016/S0140-6736(22)00536-0] [PMID]
3. Meri MA, Al-Hakeem AH, Al-Abeadi RS. An overview on thalassemia: A review article. Med Sci J Adv Res. 2022;3(1):26-32. [DOI:10.46966/msjar.v3i1.36]
4. Sadiq IZ, Abubakar FS, Usman HS, Abdullahi AD, Ibrahim B, Kastayal BS, et al. Thalassemia: Pathophysiology, diagnosis, and advances in treatment. Thalass Rep. 2024;14(4):81-102. [DOI:10.3390/thalassrep14040010]
5. Chaichompoo P, Svasti S, Smith DR. The Roles of Mitophagy and Autophagy in Ineffective Erythropoiesis in β-Thalassemia. Int J Mol Sci. 2022;23(18):10811. [DOI:10.3390/ijms231810811] [PMID] [PMCID]
6. Iyevhobu KO, Okobi TJ, Usoro ER, Ivie AA, Ken-Iyevhobu BA, Victoria OO. Overview of beta-thalassemia. Thalassemia Syndromes-New Insights and Transfusion Modalities: IntechOpen; 2023.
7. Buttari B, Profumo E, Caprari P, Massimi S, Sorrentino F, Maffei L, et al. Phenotypical and functional abnormalities of circulating neutrophils in patients with β-thalassemia. Ann Hematol. 2020;99(10):2265-77. [DOI:10.1007/s00277-020-04213-0] [PMID]
8. Shihab RN, Al-Aubaidi IK. Toxoplasmosis in thalassemic iraqi patients: serological and hematological study. Rom J Infect Dis. 2024;27(2):97-103. [DOI:10.37897/RJID.2024.2.5]
9. Sultan SA, Al-Kuraishi AH, Mahdi AAH. Effect of Toxoplasma gondii on the Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 in Women with Toxoplasmosis. Mustansiriya Med J. 2023;22(1):44-9. [DOI:10.4103/mj.mj_39_22]
10. Elsayh KI, Mohammed WS, Zahran AM, Saad K. Leukocytes apoptosis and adipocytokines in children with beta thalassemia major. Clin Exp Med. 2016;16(3):345-50. [DOI:10.1007/s10238-015-0361-6] [PMID]
11. Calder PC, Carr AC, Gombart AF, Eggersdorfer M. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients. 2020;12(4):1181. [DOI:10.3390/nu12041181] [PMID] [PMCID]
12. Namazi Bayegi S, Ali Hamidieh A, Behfar M, Saghazadeh A, Bozorgmehr M, Tajik N, et al. Unbalanced T-cell subsets in pediatric patients with beta-thalassemia. Hum Immunol. 2023;84(3):224-34. [DOI:10.1016/j.humimm.2022.12.003] [PMID]
13. Beshir MR, Abd-Alaziz MB, Ismail WI, Baz EG. Evaluation of Immune System Alterations in Children with β-Thalassemia Major: Single-Center Egyptian Study. Zagazig Univ Med J. 2024;30(6):2280-9. [DOI:10.21608/zumj.2024.278832.3272]
14. Miri-Aliabad G, Rezaeifar A, Salarzaei M. Comparison of immunoglobulins status in splenectomized and non-splenectomized patients with major beta-thalassemia. J Pediatr Rev. 2022;10(2):161-6. [DOI:10.32598/jpr.10.2.951.2]
15. Salman HF, Imtithal IJ, Khudhair N. Immunological Significance of Meconium-Stained Amniotic Fluid with Complement Factors C3 and CD4 Levels for Pregnancy Health. Integr Biomed Sci. 2024;8(3):1-7. [DOI:10.25163/angiotherapy.839546]
16. SAS Institute Inc. Statistical Analysis Software (SAS) User's Guide Version 9.6; ; Cary, NC. USA: SAS Publishing Inc; 2021.
17. Yaseen A, Hasan T. Seroprevalence of toxoplasmosis in a sample of patients with renal failure. J Coll Basic Educ. 2024;30(125):941-50. [DOI:10.35950/cbej.v30i125.12176]
18. Al-Aubaidi IK, Saeed SA, Jaaffar AI. Blood lymphocytes detection in Iraqi diabetic type 2 patients infected with chronic toxoplasmosis by using flow cytometry. Indian J Forensic Med Toxicol. 2020;14(4):2297-303.
19. Abd El-Latif NF, Salem AI, Sadek NA, Salah SAM, Shalaby DG, Elhadad H. Serological and molecular detection of Toxoplasma gondii in ß. thalassemia patients. J Parasit Dis. 2023;47(4):778-86. [DOI:10.1007/s12639-023-01624-4] [PMID] [PMCID]
20. Hanifehpour H, Samsam Shariat SK, Ghafari MS, Kheirandish F, Saber V, Fallahi S. Serological and Molecular Diagnosis of Toxoplasma gondii Infections in Thalassemia Patients. Iran J Parasitol. 2019;14(1):20-8. [DOI:10.18502/ijpa.v14i1.714] [PMID] [PMCID]
21. Dabirzadeh M, Yusefnia H, Azizi H, Raeghi S, Mirahmadi H. Comparison of nested PCR and ELISA techniques in diagnosis of toxoplasmosis infection in thalassemia patients by targeting the RE gene. Ann Parasitol. 2022;68(3):447-52.
22. Tambunan BA, Ugrasena IDG, Aryati A. Impact of Hemin on Interleukin-21 Levels and Plasma Cells in Transfusion-Dependent Thalassemia with Positive and Negative Allo-Autoantibody. Int J Gen Med. 2023;16:47-56. [DOI:10.2147/IJGM.S397317] [PMID] [PMCID]
23. Tenneti P, Chojecki A, Knovich MA. Iron overload in the HCT patient: a review. Bone Marrow Transplant. 2021;56(8):1794-804. [DOI:10.1038/s41409-021-01244-7] [PMID]
24. Gluba-Brzózka A, Franczyk B, Rysz-Górzyńska M, Rokicki R, Koziarska-Rościszewska M, Rysz J. Pathomechanisms of Immunological Disturbances in β-Thalassemia. Int J Mol Sci. 2021;22(18):9677. [DOI:10.3390/ijms22189677] [PMID] [PMCID]
25. Maffei L, Sorrentino F, Caprari P, Taliani G, Massimi S, Risoluti R, et al. HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives. Front Mol Biosci. 2020;7:7. [DOI:10.3389/fmolb.2020.00007] [PMID] [PMCID]
26. Arneth B. Molecular Mechanisms of Immune Regulation: A Review. Cells. 2025;14(4):283. [DOI:10.3390/cells14040283] [PMID] [PMCID]
27. Shokrgozar N, Amirian N, Ranjbaran R, Bazrafshan A, Sharifzadeh S. Evaluation of regulatory T cells frequency and FoxP3/GDF-15 gene expression in β-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels. Ann Hematol. 2020;99(3):421-9. [DOI:10.1007/s00277-020-03931-9] [PMID]
28. Ehsanipour F, Faranoush P, Foroughi-Gilvaee MR, Sadighnia N, Fallahpour M, Motamedi M, et al. Evaluation of immune system in patients with transfusion-dependent beta-thalassemia in Rasoul-e-Akram Hospital in 2021: A descriptive cross-sectional study. Health Sci Rep. 2022;5(6):e871. [DOI:10.1002/hsr2.871] [PMID] [PMCID]
29. Al-Kaif L, Al-Ameri H, Alfatlawi WRO, Mahdi AE, Al-Khafaji YAK, Al-Saadi MA, et al. Detection of CTLA-4 level and humeral immune response after the second dose of COVID-19 vaccine in certain Iraqi provinces participants. PLoS One. 2024;19(1):e0296521. [DOI:10.1371/journal.pone.0296521] [PMID] [PMCID]
30. Naskar S, Sriraman N, Sarkar A, Mahajan N, Sarkar K. Tumor antigen presentation and the associated signal transduction during carcinogenesis. Pathol Res Pract. 2024;261:155485. [DOI:10.1016/j.prp.2024.155485] [PMID]
31. Abd-Alsahib S, Abd-Alhussein A, Jameel YM. Estimation of CD8 Parameter Level in Thalassemia Patients. J Tech. 2022;4(Special Issue):110-5. [DOI:10.51173/jt.v4i33.686]
32. Robert P, Limozin L, van der Merwe PA, Bongrand P. CD8 Co-Receptor Enhances T-Cell Activation without Any Effect on Initial Attachment. Cells. 2021;10(2):429. [DOI:10.3390/cells10020429] [PMID] [PMCID]
33. Sae-Khow K, Charoensappakit A, Leelahavanichkul A. Neutrophil diversity (immature, aged, and low-density neutrophils) and functional plasticity: possible impacts of iron overload in β-thalassemia. Int J Mol Sci. 2024;25(19):10651. [DOI:10.3390/ijms251910651] [PMID] [PMCID]
34. Al-Sultany MM, Mohammad HQ. Estimation of CD4 and CD8 T Lymphocyte Cell Count in β-Thalassemia Major Patients. J Med Sci. 2024;1(1):1-6.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
Iranian Journal of Medical Microbiology by Farname is licensed under CC BY-NC 4.0
